Quinine induced thrombocytopenia is –
**Core Concept**
Quinine-induced thrombocytopenia is a rare but serious side effect of quinine, a medication used to treat malaria. This condition is characterized by the formation of antibodies against platelet glycoproteins, leading to platelet destruction and thrombocytopenia. The underlying mechanism involves the development of an immune response against platelet antigens.
**Why the Correct Answer is Right**
The development of quinine-induced thrombocytopenia is associated with the formation of autoantibodies against platelet glycoproteins, specifically GPIIb/IIIa. These autoantibodies bind to the platelet surface and activate the complement system, leading to platelet destruction and subsequent thrombocytopenia. The mechanism is similar to that of heparin-induced thrombocytopenia, another immune-mediated condition.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not accurately describe the mechanism of quinine-induced thrombocytopenia. The condition is not caused by a direct toxic effect of quinine on platelets.
**Option B:** This option is incorrect as it does not specify the correct platelet glycoproteins involved in quinine-induced thrombocytopenia. While platelet glycoproteins are indeed involved, the specific GPIIb/IIIa complex is the target of autoantibodies.
**Option C:** This option is incorrect as it does not accurately describe the role of the immune system in quinine-induced thrombocytopenia. The condition is an autoimmune response, not a direct toxic effect of quinine.
**Option D:** This option is incorrect as it does not specify the correct platelet glycoproteins involved in quinine-induced thrombocytopenia. While platelet glycoproteins are indeed involved, the specific GPIIb/IIIa complex is the target of autoantibodies.
**Clinical Pearl / High-Yield Fact**
Quinine-induced thrombocytopenia is a rare but serious side effect of quinine, and patients taking quinine should be monitored regularly for signs of thrombocytopenia. The condition can be treated with platelet transfusions and discontinuation of quinine.
**Correct Answer:** D. Quinine-induced thrombocytopenia is caused by autoantibodies against platelet glycoproteins, specifically GPIIb/IIIa.